| Financial Year |
March 31 2023 |
| Monetary Funds |
1,430,413,963.06 |
| Held-for-trading Financial Assets |
190,633,684.19 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,918,232,033.06 |
| Advances to Suppliers |
234,024,325.37 |
| Other Receivables |
7,568,646.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,654,989,276.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
64,082,781.53 |
| Total Current Assets |
7,064,818,626.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
230,907,125.47 |
| Investment Properties |
209,961,430.59 |
| Fixed Assetes |
1,436,256,629.78 |
| Under-construction Projects |
150,973,241.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
131,581,409.37 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,751,399.15 |
| Deferred Income Tax Assets |
73,245,531.73 |
| Other Non-Current Assets |
138,319,535.91 |
| Sub-Total of Non-Current Assets |
2,723,003,266.90 |
| Total Assets |
9,787,821,893.53 |
| Short-Term Loans |
1,110,000,000.00 |
| Trading Financial liabilities |
1,793,951.19 |
| Notes Payable |
447,747,137.24 |
| Accounts Payable |
581,721,613.42 |
| Accounts Received In Advance |
3,273,739.68 |
| Employee Compensation Payable |
42,641,316.13 |
| Taxes Payable |
21,229,236.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
146,831,872.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
116,610,456.96 |
| Other Current Liabilities |
74,746,754.21 |
| Sub-Total of Current Liabilities |
2,680,627,546.47 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,664,376.78 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
935,097,236.59 |
| Total Liabilities |
3,615,724,783.06 |
| Paid-In Capital(Or Share Stock) |
1,112,368,051.00 |
| Capital Surplus |
1,284,790,441.37 |
| Surplus Reserve |
402,288,851.88 |
| LESS:Treasury Stock |
265,286,279.10 |
| Undistributed Profits |
3,625,303,745.33 |
| Minority Stockholder's Interest |
10,945,803.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,161,151,306.49 |
| Owner's Equity（Stockholder's Equity） |
6,172,097,110.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,787,821,893.53 |
